To require the Medicare Payment Advisory Commission (MedPAC) submit to Congress two reports on arrangements with pharmacy benefit managers with respect to prescription drug plans and MA–PD plans.
About This Bill
Committee
Latest Action · July 25, 2023
Read twice and referred to the Committee on Finance.
PBM Reporting Transparency Act
This bill requires the Medicare Payment Advisory Commission to report certain information about pharmacy benefit managers (PBMs) under the Medicare prescription drug benefit and Medicare Advantage.
Specifically, the commission must report on trends in agreements between PBMs and prescription drug plans, the impact of any differences in agreements on out-of-pocket spending for enrollees and pharmacy reimbursements, and any appropriate recommendations. The commission must submit an updated report two years after its initial report.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.